Wall Street Zen Downgrades Intuitive Surgical (NASDAQ:ISRG) to Hold

Key Points

• Wall Street Zen downgraded Intuitive Surgical from buy to hold, adding to a mixed analyst picture on the stock.
• The company recently beat quarterly expectations, reporting $2.50 EPS versus $2.08 expected and $2.77 billion in revenue, up 23% year over year.
• Despite strong fundamentals, the shares were trading at $438.10, near the low end of their 52-week range, while insiders have also sold shares in recent months.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research report issued on Sunday.

Several other brokerages have also commented on ISRG. Evercore decreased their target price on shares of Intuitive Surgical from $550.00 to $480.00 and set a "neutral" rating for the company in a research note on Monday, April 6th. Jefferies Financial Group decreased their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a "hold" rating for the company in a research note on Wednesday, April 22nd. TD Cowen decreased their target price on shares of Intuitive Surgical from $660.00 to $585.00 and set a "buy" rating for the company in a research note on Wednesday, April 22nd. Robert W. Baird raised their target price on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an "outperform" rating in a research note on Wednesday, April 22nd. Finally, Barclays set a $651.00 price target on shares of Intuitive Surgical and gave the company an "overweight" rating in a research report on Thursday, April 23rd. Nineteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $579.33.

Intuitive Surgical Trading Down 0.4%

Shares of NASDAQ ISRG opened at $438.10 on Friday. The stock has a fifty day simple moving average of $458.62 and a two-hundred day simple moving average of $510.61. The firm has a market cap of $155.16 billion, a price-to-earnings ratio of 53.10, a price-to-earnings-growth ratio of 3.50 and a beta of 1.51. Intuitive Surgical has a 1-year low of $417.74 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same period last year, the business posted $1.81 earnings per share. Intuitive Surgical's quarterly revenue was up 23.0% compared to the same quarter last year. Analysts forecast that Intuitive Surgical will post 8.57 EPS for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 220 shares of Intuitive Surgical stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark Brosius sold 645 shares of Intuitive Surgical stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $485.01, for a total transaction of $312,831.45. Following the completion of the sale, the senior vice president directly owned 1,613 shares of the company's stock, valued at approximately $782,321.13. This trade represents a 28.57% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 5,701 shares of company stock valued at $2,783,807 over the last ninety days. Corporate insiders own 0.60% of the company's stock.

Institutional Investors Weigh In On Intuitive Surgical

A number of large investors have recently added to or reduced their stakes in ISRG. Holos Integrated Wealth LLC bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $25,000. Newbridge Financial Services Group Inc. grew its position in Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 33 shares during the period. Greykasell Wealth Strategies Inc. purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth $27,000. Olistico Wealth LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $28,000. Finally, Caitlin John LLC purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth $30,000. Institutional investors own 83.64% of the company's stock.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive unveiled more than 100 upcoming upgrades for its da Vinci 5 robotic surgery system, including improved force-feedback tools, telecollaboration features, and security/reliability enhancements, which could strengthen the company’s competitive moat and support future procedure growth. Intuitive Surgical’s Da Vinci 5 Upgrades Aim To Deepen Moat For Investors
• Positive Sentiment: Intuitive also announced innovations tied to its “Quintuple Aim” strategy, reinforcing product development momentum and the company’s push to improve surgeon autonomy and operating-room efficiency. Intuitive Announces Innovations to Advance Quintuple Aim
• Positive Sentiment: Wall Street commentary remains moderately optimistic, with analysts still bullish on Intuitive Surgical’s long-term prospects despite recent underperformance versus the broader market. Are Wall Street Analysts Bullish on Intuitive Surgical Stock?
• Neutral Sentiment: Investor interest continues around the SP platform, where strong procedure growth suggests an important future opportunity, but it remains unclear whether this is true addressable-market expansion or mostly a shift within existing robotic procedures. ISRG's SP Platform: Early-Stage Growth or Next TAM Expansion Driver?
• Neutral Sentiment: There was also minor insider selling by an executive, but the transactions were very small and made under a pre-arranged 10b5-1 plan, so the signal for investors is limited. Mark Brosius insider transaction
• Negative Sentiment: The stock has also been hurt by recent weakness after earnings, with market commentary noting a roughly 7% decline since the last report, reflecting concern that the shares may need more proof of sustained acceleration. Why Is Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report?
• Negative Sentiment: Several articles also point out that ISRG has significantly lagged the market over the past six months, which may be keeping valuation-sensitive investors on the sidelines. 3 Big Reasons ISRG Should Be On Your Watchlist

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.